T409-0574 Screening compound: 6-(azepane-1-carbonyl)-2-(4-cyclobutanecarbonylpiperazin-1-yl)-4,5,6,7-tetrahydro-1,3-benzothiazole

T409-0574 Screening compound: 6-(azepane-1-carbonyl)-2-(4-cyclobutanecarbonylpiperazin-1-yl)-4,5,6,7-tetrahydro-1,3-benzothiazole
T409-0574 Screening compound: 6-(azepane-1-carbonyl)-2-(4-cyclobutanecarbonylpiperazin-1-yl)-4,5,6,7-tetrahydro-1,3-benzothiazole alternative view

Chemical Structure Depiction of ChemDiv screening compound T409-0574
6-(azepane-1-carbonyl)-2-(4-cyclobutanecarbonylpiperazin-1-yl)-4,5,6,7-tetrahydro-1,3-benzothiazole

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

T409-0574

Molecular Formula

C23H34N4O2S (C23 H34 N4 O2 S)

Compound Name

6-(azepane-1-carbonyl)-2-(4-cyclobutanecarbonylpiperazin-1-yl)-4,5,6,7-tetrahydro-1,3-benzothiazole

IUPAC name

6-(azepane-1-carbonyl)-2-(4-cyclobutanecarbonylpiperazin-1-yl)-4567-tetrahydro-13-benzothiazole

SMILES

O=C(C1CCC1)N(CC1)CCN1c1nc(CCC(C2)C(N3CCCCCC3)=O)c2s1

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

430.61

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

3.368

Distribution Coefficient, logD

3.262

Water Solubility, LogSw

-3.24

Polar Surface Area

48.891

Acid Dissociation Constant (pKa)

21.61

Base Dissociation Constant (pKb)

6.84

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

78.30

T409-0574 in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

GPCR Targeted Library (31838 compounds)

PPI Inhibitors Tripeptide Mimetics (23972 compounds)

Protein Arginine Methyltransferases Library (27925 compounds)

Protein-Protein Interaction Library (218420 compounds)

Akt-Targeted Library (14764 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Ion Channels Focused Library (26372 compounds)

Peptidomimetic Library (37031 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Metabolic
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Nervous system
  • Cardiovascular
Targets:
  • GPCR
  • Others
  • Kinases
  • Ion Channels
Mechanism of action:
  • Receptor's ligands
  • PPI modulators
  • Epigenetic
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics
  • Cyclic compounds
  • Mimetics

References: we are preparing a list of scientific research reports with T409-0574 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound T409-0574?
Check Price and Availability of T409-0574, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of T409-0574 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for T409-0574
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for T409-0574
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of T409-0574 available by request